Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ESK-001 by Alumis for Systemic Lupus Erythematosus: Likelihood of Approval
ESK-001 is under clinical development by Alumis and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase...